Sunday, September 4, 2016

Whither Goeth Hermine?

http://www.nytimes.com/2016/09/04/opinion/sunday/youre-how-old-well-be-in-touch.html?_r=0  This is a column in the Sunday Review opinion section of the NYT about age discrimination in the workplace. According to this article 20% of Americans 65 and older are working. Why are people over 50 unable to find work? The column says a network of attitudes and institutional practices is to blame.




http://www.nytimes.com/2016/09/04/technology/goodbye-ivory-tower-hello-silicon-valley-candy-store.html  This NYT article is about economists moving from academia to private companies to help analyze data and improve sales.


http://www.nytimes.com/2016/09/03/business/is-epipen-a-brand-name-or-a-generic-drug-mylan-casts-it-both-ways.html An article in the NYT about the profiteering in selling the Epipen by Mylan pharmaceuticals, which has exclusivity.  Mylan has been saying it is a generic, resulting in Medicaid overpayment. Mylan has raised the price six-fold since 2007. Shares of Mylan have dropped 15% in the weeks since the attention to Epipen's overpricing has been publicized.
http://www.nytimes.com/2016/09/04/business/at-mylan-lets-pretend-is-more-than-a-game.html



http://healthjournalism.org/blog/2016/09/modifying-use-of-some-prescription-drugs-may-reduce-fracture-risk-in-older-adults/ The JAMA Internal Medicine published a study about how changing the drug regimen of older adults may lessen the likelihood their sustaining fractures. The study was done at Dartmouth U. 21 drug classes were associated with increased fracture risk.
Photo: Marko Javorac via Flickr

http://www.nytimes.com/2016/09/13/science/south-african-mine-life-on-mars.html?_r=0 This article from the Science Times is about microbes in a South African mine. A Princeton-led team is examining a methane-fed community of microbes which could be similar to the community on Mars. There is a theory that life originated on Mars then traveled to earth by way of meteorites. This is called the earth's deep biosphere.

No comments:

Post a Comment